Stephen L. Cartt has been appointed president and chief executive officer and member of the board of directors, Asterias Biotherapeutics, Inc. Mr. Cartt replaces Pedro Lichtinger, who served in these roles since June 2014. Mr. Cartt began his career in the pharma industry at ALZA Corp., where he held a variety of R&D and commercial positions. He also served as senior director of strategic marketing at Elan Pharmaceuticals before joining Questcor in 2005. At Questcor, he served as executi...